Cargando…
Serum Lipids and Cardiovascular Disease Mortality in Iranian Population: Joint Modeling of Longitudinal and Survival Data in Tehran Lipid and Glucose Study (TLGS) Cohort
BACKGROUND: Lipid abnormalities are major risk factors of death from cardiovascular disease (CVD). As well as, lipid markers are time-dependent covariates that change with aging. Previous cohort studies have only investigated baseline measurements of lipid markers on CVD mortality. MATERIALS AND MET...
Autores principales: | Pahlavanzade, Bagher, Zayeri, Farid, Baghfalaki, Taban, Hadaeg, Farzad, Khalili, Davood, Shoaib Hamrah, Mohammad, Paul, Edwin, Azizi, Fereidoun, Abadi, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Salvia Medical Sciences Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343986/ https://www.ncbi.nlm.nih.gov/pubmed/34466521 http://dx.doi.org/10.31661/gmj.v8i0.1516 |
Ejemplares similares
-
Association of lipid markers with coronary heart disease and stroke mortality: A 15-year follow-up study
por: Pahlavanzade, Bagher, et al.
Publicado: (2019) -
BMI variability and incident diabetes mellitus, Tehran Lipid and Glucose Study (TLGS)
por: Mehran, Ladan, et al.
Publicado: (2022) -
Validation of the Framingham hypertension risk score in a middle eastern population: Tehran lipid and glucose study (TLGS)
por: Koohi, Fatemeh, et al.
Publicado: (2021) -
Blood Pressure and Hypertension: Findings from 20 Years of the Tehran Lipid and Glucose Study (TLGS)
por: Abdi, Hengameh, et al.
Publicado: (2018) -
Socio-Demographic Determinants of Health-Related Quality of Life in Tehran Lipid and Glucose Study (TLGS)
por: Jalali-Farahani, Sara, et al.
Publicado: (2017)